Halberd Co. (OTCMKTS:HALB) Sees Significant Decrease in Short Interest

Halberd Co. (OTCMKTS:HALB) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 700 shares, a drop of 96.9% from the December 31st total of 22,300 shares. Based on an average daily trading volume, of 1,645,800 shares, the days-to-cover ratio is presently 0.0 days.

Halberd Trading Down 3.1 %

HALB traded down $0.00 on Tuesday, hitting $0.00. 106,855 shares of the company were exchanged, compared to its average volume of 622,741. Halberd has a 12 month low of $0.00 and a 12 month high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.